StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Annual voluntary employee turnover rate by Year

Annual voluntary employee turnover rate (%) (%)

Moderna Annual voluntary employee turnover rate: 29.0% in FY2025, up 14.0 pts from a year earlier.

Latest, FY2025
29.0%
Period ended Dec 31, 2025
Change on a year earlier
+14.0 pts
15.0% in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below

Where the FY2025 figure comes from

“49% 49% 49% 10% 15% 29% Hispanic / Latinx 8% 9% 8%”

Source: 2025 Impacting Human Health Report ↗

Reported in Moderna Corporate Responsibility / Impacting Human Health Reports.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAnnual voluntary employee turnover rate (%) (%)Year on yearSource
FY2025Dec 31, 202529.0%+14.0 pts2025 Impacting Human Health Report ↗
FY2024Dec 31, 202415.0%+5.0 pts2025 Impacting Human Health Report ↗
FY2023Dec 31, 202310.0%0.0 pts2025 Impacting Human Health Report ↗
FY2022Dec 31, 202210.0%+2.6 pts2024 Impacting Human Health Report ↗
FY2021Dec 31, 20217.4%–2023 ESG Report ↗

Cite this data

StockData. (2026). Moderna Annual voluntary employee turnover rate (%), annual FY2021–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/hc-turnover-pct

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.